Agonists of TLR7 and TLR8 including imidazoquinolines are currently being used or tested in clinical trials as anti‐viral and anti‐cancer drugs (Iyer, 2015; Peris & Fargnoli, 2015). The gene discussed is TLR7; the disease is cancer.